DMK PHARMACEUTICALS CORPORATION Total Liabilities
DMK PHARMACEUTICALS CORPORATION had Total Liabilities of $13.92 million as of 2023-09-30, per its 10-Q filed 2023-11-14.
Discontinued › Balance Sheet › Liabilities
us-gaap:Liabilities · last filed 2023-11-14
- 2023-09-30: Liabilities $13.92M.
- 2023-06-30: Liabilities $16.24M.
- 2023-03-31: Liabilities $18.60M.
- 2022-12-31: Liabilities $11.58M.
| Period end | Liabilities | Liabilities as first filed |
|---|---|---|
| 2023-09-30 | $13.92M 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $16.24M 10-Q · filed 2023-08-21 | |
| 2023-03-31 | $18.60M 10-Q · filed 2023-05-15 | |
| 2022-12-31 | $11.58M 10-Q · filed 2023-11-14 | |
| 2022-09-30 | $9.13M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $10.65M 10-Q · filed 2022-08-10 | |
| 2022-03-31 | $14.65M 10-Q · filed 2022-05-16 | |
| 2021-12-31 | $12.42M 10-K · filed 2023-03-16 | |
| 2021-09-30 | $10.61M 10-Q · filed 2021-11-22 | |
| 2021-06-30 | $17.03M 10-Q · filed 2021-11-22 | |
| 2021-03-31 | $25.46M 10-Q · filed 2021-11-22 | |
| 2020-12-31 | $27.37M 10-K · filed 2022-03-31 | |
| 2020-09-30 | $23.44M 10-K · filed 2021-04-15 | $16.52M 10-Q · filed 2020-11-09 |
| 2020-06-30 | $19.63M 10-K · filed 2021-04-15 | $16.58M 10-Q · filed 2020-08-17 |
| 2020-03-31 | $13.99M 10-K · filed 2021-04-15 | $12.06M 10-Q · filed 2020-05-18 |
| 2019-12-31 | $14.84M 10-K · filed 2021-04-15 | $11.80M 10-K · filed 2020-03-30 |
| 2019-09-30 | $12.54M 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $13.28M 10-Q · filed 2019-08-08 | |
| 2019-03-31 | $12.88M 10-Q · filed 2019-05-09 | |
| 2018-12-31 | $11.67M 10-K · filed 2020-03-30 | |
| 2018-09-30 | $12.40M 10-Q · filed 2018-11-09 | |
| 2018-06-30 | $13.96M 10-Q · filed 2018-08-09 | |
| 2018-03-31 | $10.33M 10-Q · filed 2018-05-10 | |
| 2017-12-31 | $11.86M 10-K · filed 2019-03-15 | |
| 2017-09-30 | $10.28M 10-Q · filed 2017-11-14 | |
| 2017-06-30 | $10.11M 10-Q · filed 2017-08-14 | |
| 2017-03-31 | $12.82M 10-Q · filed 2017-05-12 | |
| 2016-12-31 | $12.51M 10-K · filed 2018-03-16 | |
| 2016-09-30 | $11.99M 10-Q · filed 2016-11-14 | |
| 2015-12-31 | $2.75M 10-K · filed 2017-03-30 |